Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Marion Dajon"'
Autor:
Marion Dajon, Kristina Iribarren, Florent Petitprez, Solenne Marmier, Audrey Lupo, Mélanie Gillard, Hanane Ouakrim, Navas Victor, Di Bartolo Vincenzo, Pierre Emmanuel Joubert, Oliver Kepp, Guido Kroemer, Marco Alifano, Diane Damotte, Isabelle Cremer
Publikováno v:
OncoImmunology, Vol 8, Iss 1 (2019)
In non-small cell lung carcinoma (NSCLC), stimulation of toll-like receptor 7 (TLR7), a receptor for single stranded RNA, is linked to tumor progression and resistance to anticancer chemotherapy. However, the mechanism of this effect has been elusive
Externí odkaz:
https://doaj.org/article/3d8711a3d69047dc912aa59845b4beaa
Autor:
Xavier Marniquet, Marion Dajon, Julie Montegut, Maria Elena Giusepponi, Michela Pecoraro, Elena Vicentini, Francesca Morandini, Floriana Zanderigo, Denise Federico, Odile Bonnin, Gregory Neveu, Charlotte Blanc, Christelle Marcou, Juliette Lavaux, Michel Didier, Galina Boldina, Jacques Dumas, Thomas Bouqin, Annabelle Milla, Hugh Watson, Kara Carter, Antoine Alam
Publikováno v:
Journal of Hepatology. 77:S872
Autor:
Élodie Pramil, Cécile Bandet, Sami Ayari, Sara Ghezzal, Hélène Kaplon, Marion Dajon, Bárbara G. Postal, Jules Russick, Ray El Boustany, Annaelle Jarossay
Publikováno v:
médecine/sciences. 33:197-200
Les doctorants organisateurs de ces journees proposent un resume des principaux evenements scientifiques qui se sont deroules les 25 et 26 mai 2016 au centre de recherche des Cordeliers (CRC) lors des journees de l’ecole « physiologie, physiopatho
Publikováno v:
Cancer Research. 78:5752-5752
TLR7 agonists are currently under investigations for their ability to enhance anti-tumor immune responses. However, in some tumor models, these agonists also stimulate tumor cells, which can express high levels of TLR7, a receptor for single-stranded
Publikováno v:
Immunobiology. 222(1)
Toll-like receptors (TLRs) are a family of transmembrane receptors that recognize various pathogen- and damage-associated molecular pattern molecules playing an important role in inflammation by activating NF-кB. TLRs, mainly expressed by innate imm
Publikováno v:
Cancer Immunology Research. 4:A124-A124
TLR7 agonists are currently under investigations for their ability to enhance anti-tumor immune responses. However, in some tumor models, these agonists can also stimulate tumor cells, which express high levels of TLR7. In Non-Small-Cell Lung Carcino
Publikováno v:
OncoImmunology. 4:e991615
Toll-like receptor 7 (TLR7) agonists are under investigation for their ability to enhance antitumor immune responses. However, these agonists can also stimulate TLR7-expressing tumor cells. High TLR7 expression in the primary tumor confers poor clini